MinalAtulBarveMD(She/Her)

Clinical Trials

• Salvage Ovarian FANG™ Vaccine + Carboplatinum Start of enrollment: 2013 Jun 01

  Completed

  Phase 2

• A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma Start of enrollment: 2016 Feb 10

  Completed

  Phase 2

• Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers Start of enrollment: 2016 Jun 03

  Completed

  Phase 2

• Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies Start of enrollment: 2019 May 17

  Recruiting

  Phase 1

• A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation Start of enrollment: 2021 Aug 03

  Active, not recruiting

  Phase 1

  Roles: Contact

• Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS Start of enrollment: 2022 May 31

  Recruiting

  Phase 1

• A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas Start of enrollment: 2022 Mar 28

  Recruiting

  Phase 1

• IMM2902, a HER2/SIRPα Bispecific mAb-Trap Antibody-receptor Fusion Protein, in Patients With HER2-expressing Advanced Solid Tumors Start of enrollment: 2022 Jun 20

  Recruiting

  Phase 1

• TH1902 in Patients With Advanced Solid Tumors Start of enrollment: 2021 Mar 04

  Recruiting

  Phase 1

• Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers Start of enrollment: 2020 Sep 23

  Recruiting

  Phase 1

• Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors Start of enrollment: 2021 Aug 18

  Recruiting

  Phase 1

• A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) Start of enrollment: 2021 Jun 22

  Recruiting

  Phase 1

• Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study Start of enrollment: 2021 Jan 18

  Recruiting

  Phase 2

• A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation Start of enrollment: 2023 Dec 28

  Recruiting

  Phase 1

• Join now to see all